Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’
Hansoh gave a bullish assessment of China’s biopharma role, arguing that it is “fully transitioning from the ‘follower’ to the ‘frontrunner’ phase.”
Nick Paul Taylor
Aug 26, 2026 9:33am
Why a congressman says China is 'beating us on our ground game'
Aug 25, 2026 9:45am
Why are Chinese biotech CEOs unfazed about rising US tensions?
Aug 20, 2026 8:20am
After 2 undisclosed deaths, can China’s IIT still be trusted?
Aug 17, 2026 7:20am
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
Jul 27, 2026 10:08am
Roche Diagnostics growth remains muted amid China headwinds
Jul 23, 2026 8:13am
